Article
Erythromycin block of the HERG K+ channel: accessibility to F656 and Y652.
Biochemical and biophysical research communications - 10 Mar 2006
Duncan Rona S, Ridley John M, Dempsey Christopher E, Leishman Derek J, Leaney Joanne L, Hancox Jules C, Witchel Harry J
Abstract excerpt
The HERG potassium channel might have a non-canonical drug binding site, distinct from the channel's inner cavity, that could be responsible for elements of closed-state pharmacological inhibition of the channel. The macrolide antibiotic erythromycin is a drug that may block unconventionally because of its size. Here we used whole-cell patch-clamp recording at 37 degrees C from heterologously expressed HERG...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
